Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen

Background Next generation, higher valency pneumococcal conjugate vaccines (PCVs) are assessed and licensed by comparing the immune response across serotypes shared with the PCVs that are standard of care for prevention of pneumococcal disease.Methods Using a previously qualified method we predicted...

Full description

Bibliographic Details

Published in:	Expert Review of Vaccines
Main Authors:	Josiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee, Jessica Weaver
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Antibodies child immunization schedule modeling and simulation pharmacometrics pneumococcal vaccines
Online Access:	https://www.tandfonline.com/doi/10.1080/14760584.2024.2335323